Stock ENZN ENZON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Enzon Pharmaceuticals, Inc. Other OTC

Equities

ENZN

US2939041081

Biotechnology & Medical Research

Business Summary

Enzon Pharmaceuticals, Inc. (Enzon) is an acquisition vehicle company. The Company intends to become an acquisition platform. The Company utilizes its net operating loss carryforwards (NOLs) and improves stockholder value. It manages its source of royalty revenues from existing licensing arrangements with other companies.

Managers

Managers TitleAgeSince
Richard L. Feinstein CEO
 Chief Executive Officer 80 13/13/13

Members of the board

Members of the board TitleAgeSince
Randolph Read CHM
 Chairman 71 04/20/04
Jaffrey Adam Firestone BRD
 Director/Board Member 67 01/22/01
Jordan Bleznick BRD
 Director/Board Member 68 04/20/04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 74,214,603 66,170,649 ( 89.16 %) 0 89.16 %

Shareholders

NameEquities%Valuation
Icahn Associates Holding LLC
48.58 %
36,056,636 48.58 % 3 M $
Jonathan Couchman
9.581 %
7,110,690 9.581 % 547 523 $
OrbiMed Advisors LLC
1.617 %
1,200,000 1.617 % 92 400 $
MYREXIS, INC.
0.8533 %
633,264 0.8533 % 48 761 $
Oppenheim Fonds Trust GmbH
0.5049 %
374,700 0.5049 % 28 852 $
Randolph Read
0.2695 %
200,000 0.2695 % 15 400 $
Jordan Bleznick
0.1347 %
100,000 0.1347 % 7 700 $
Merrill Lynch Investment Managers, Inc.
0.0740 %
54,900 0.0740 % 4 227 $
Medical Strategy GmbH
0.0509 %
37,800 0.0509 % 2 911 $
Sella SGR SpA
0.0230 %
17,100 0.0230 % 1 317 $

Company contact information

Enzon Pharmaceuticals, Inc.

20 Commerce Drive Suite 135

07016, Cranford

+732 980 4500

http://www.enzon.com
address Enzon Pharmaceuticals, Inc.(ENZN)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+3.17% 108B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+10.38% 105B
ARGENX SE Stock argenx SE
+1.57% 23.46B
BIONTECH SE Stock BioNTech SE
-12.68% 21.72B
GENMAB A/S Stock Genmab A/S
-7.05% 18.64B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-37.64% 17.45B
BEIGENE, LTD. Stock BeiGene, Ltd.
-6.85% 17.19B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.16% 13.99B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+38.04% 12.53B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ENZN Stock
  4. ENZN Stock
  5. Company Enzon Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW